Researchers discover key mutation in acute myeloid leukemia – 4
Narrator: This is NIH Health Matters. I’m Joe Balintfy. Acute myeloid leukemia patients with a specific gene mutation survived the aggressive blood cancer only about a year, while those without it survived more than three. Dr. Tim Ley at the Washington University School of Medicine in St. Louis says, identifying this mutation could help determine whether or not to intensify treatment early.
Ley: What that generally means is that if the patient has a donor for an allogenic bone marrow transplant available, in first remission, what we do in poor risk patients is we transplant them immediately because we know that without a transplant they’re not likely to do very well.
Narrator: For more details, visit www.cancer.gov. Health Matters is produced by the National Institutes of Health, part of the U.S. Department of Health and Human Services.
About NIH Radio
NIH Radio offers free audio news programs from the National Institutes of Health, your reliable source for health information.
All NIH Radio content is in the public domain and can be used without charge or restriction provided that it is not used to misrepresent our agency nor used to suggest we endorse any private organization, product, or service.
NIH Radio is a service of the Office of Communications & Public Liaison.